{"content":"<li class=\"n-box-item date-title\" data-end=\"1372391999\" data-start=\"1372305600\" data-txt=\"Friday, December 20, 2019\">Thursday, June 27, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1111352\" data-ts=\"1372376440\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPR\" target=\"_blank\">SPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1111352\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spirit AeroSystems (NYSE:SPR) receives a $60M contract from Sikorsky Aircraft to supply the...</a></h4><p>Spirit AeroSystems (NYSE:<a href=\"https://seekingalpha.com/symbol/SPR\" title=\"Spirit AeroSystems Holdings, Inc.\">SPR</a>) <a href=\"http://www.streetinsider.com/Press+Releases/Spirit+AeroSystems%2C+Inc.+Receives+Contract+to+Supply+Aircraft+Structures+for+Four+Operational+Evaluation+CH-53K+Heavy+Lift+Helicopters/8457041.html\" target=\"_blank\">receives a $60M contract</a> from Sikorsky Aircraft to supply the major structural cockpit and cabin components of four additional CH-53K heavy lift helicopters. Designated System Demonstration Test Articles, the four production-representative aircraft will be used by the U.S. Marine Corps to evaluate the helicopter's mission capabilities under operating conditions. Shares <font color=\"red\">-2.9%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"1111352\" data-linked=\"Spirit AeroSystems (NYSE:SPR) receives a $60M contract from Sikorsky Aircraft to supply the...\" data-tweet=\"$SPR - Spirit AeroSystems (NYSE:SPR) receives a $60M contract from Sikorsky Aircraft to supply the major structural cockpit and cabin components of four additional CH-53K heavy lift helicopters. Designated System Demonstration Test Articles, the four pr... https://seekingalpha.com/news/1111352?source=tweet\" data-url=\"https://seekingalpha.com/news/1111352\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1111342\" data-ts=\"1372375255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAMP\" target=\"_blank\">CAMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1111342\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on CalAmp (NASDAQ:CAMP): Q1 beats across the board on a 22.5% jump in total sales. Wireless...</a></h4><p>More on CalAmp (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CAMP\" title=\"CalAmp Corp.\">CAMP</a>): <a href=\"https://seekingalpha.com/market_currents/post/1110952\" target=\"_blank\">Q1 beats</a> across the board on a 22.5% jump in total sales. Wireless Datacom revenue up 29% over prior year Q1 to $40.9M. For Q2, the company projects its EPS to come in  around $0.14 to $0.18 per share on revenues in the range of $53M to $57M. That's in line with the $0.16 per share in earnings on $53.7M in revenue expected by the Street. Shares <font color=\"green\">+1.7%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"1111342\" data-linked=\"More on CalAmp (NASDAQ:CAMP): Q1 beats across the board on a 22.5% jump in total sales. Wireless...\" data-tweet=\"$CAMP - More on CalAmp (NASDAQ:CAMP): Q1 beats across the board on a 22.5% jump in total sales. Wireless Datacom revenue up 29% over prior year Q1 to $40.9M. For Q2, the company projects its EPS to come in around $0.14 to $0.18 per share on revenues in ... https://seekingalpha.com/news/1111342?source=tweet\" data-url=\"https://seekingalpha.com/news/1111342\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1111232\" data-ts=\"1372368646\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRA\" target=\"_blank\">TLRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1111232\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers, as of 5:15 p.m.: TRMR +14%. MCP +10%. G +8%. GTI +3%. NKE +3%....</a></h4><b>After-hours top gainers, as of 5:15 p.m.:</b> TRMR <font color=\"green\">+14%</font>. MCP <font color=\"green\">+10%</font>. <a href='https://seekingalpha.com/symbol/G' title='Genpact Limited'>G</a> <font color=\"green\">+8%</font>. GTI <font color=\"green\">+3%</font>. <a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a> <font color=\"green\">+3%</font>. <br /><b>After-hours top losers:</b> <a href='https://seekingalpha.com/symbol/STRI' title='STR Holdings, Inc.'>STRI</a> <font color=\"red\">-11%</font>. <a href='https://seekingalpha.com/symbol/VOXX' title='VOXX International Corp.'>VOXX</a> <font color=\"red\">-8%</font>. <a href='https://seekingalpha.com/symbol/ACN' title='Accenture plc'>ACN</a> <font color=\"red\">-7%</font>. <a href='https://seekingalpha.com/symbol/WNC' title='Wabash National Corporation'>WNC</a> <font color=\"red\">-6%</font>. SFI <font color=\"red\">-6%</font>.<div class=\"tiny-share-widget\" data-id=\"1111232\" data-linked=\"After-hours top gainers, as of 5:15 p.m.: TRMR +14%. MCP +10%. G +8%. GTI +3%. NKE +3%....\" data-tweet=\"$TLRA $TLRA $MCPIQ - After-hours top gainers, as of 5:15 p.m.: TRMR +14%. MCP +10%. G +8%. GTI +3%. NKE +3%. After-hours top losers: STRI -11%. VOXX -8%. ACN -7%. WNC -6%. SFI -6%. https://seekingalpha.com/news/1111232?source=tweet\" data-url=\"https://seekingalpha.com/news/1111232\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1111222\" data-ts=\"1372368625\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFE\" target=\"_blank\">PFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1111222\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pfizer (NYSE:PFE) authorizes a new $10B stock repurchase program in addition to the $3.9B of...</a></h4><p>Pfizer (NYSE:<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a>) authorizes a new $10B <a href=\"http://www.streetinsider.com/Stock+Buybacks/Pfizer+%28PFE%29+Adds+%2410B+to+Buyback+Plan/8457163.html\" target=\"_blank\">stock repurchase program</a> in addition to the $3.9B of authorization remaining under its current buyback program. Shares <font color=\"green\">+1.5%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"1111222\" data-linked=\"Pfizer (NYSE:PFE) authorizes a new $10B stock repurchase program in addition to the $3.9B of...\" data-tweet=\"$PFE - Pfizer (NYSE:PFE) authorizes a new $10B stock repurchase program in addition to the $3.9B of authorization remaining under its current buyback program. Shares +1.5% AH. https://seekingalpha.com/news/1111222?source=tweet\" data-url=\"https://seekingalpha.com/news/1111222\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1111052\" data-ts=\"1372365128\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCPIQ\" target=\"_blank\">MCPIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1111052\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Molycorp (MCP) +4.6% AH on news the SEC completed its investigation into the accuracy of the...</a></h4>Molycorp (MCP) <font color=\"green\">+4.6%</font> AH on news the SEC completed its <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/656261\">investigation</a> into the accuracy of the company's public disclosures with <a target=\"_blank\" href=\"http://finance.yahoo.com/news/sec-staff-completes-investigation-molycorp-201702380.html\">no enforcement action recommended</a>.<div class=\"tiny-share-widget\" data-id=\"1111052\" data-linked=\"Molycorp (MCP) +4.6% AH on news the SEC completed its investigation into the accuracy of the...\" data-tweet=\"$MCPIQ - Molycorp (MCP) +4.6% AH on news the SEC completed its investigation into the accuracy of the company&#39;s public disclosures with no enforcement action recommended. https://seekingalpha.com/news/1111052?source=tweet\" data-url=\"https://seekingalpha.com/news/1111052\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1111012\" data-ts=\"1372364288\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1111012\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nike (NYSE:NKE): FQ4 EPS of $0.76 beats by $0.01. Revenue of $6.7B (+7% Y/Y) beats by $0.06B....</a></h4><b>Nike (NYSE:<a href=\"https://seekingalpha.com/symbol/NKE\" title=\"Nike Inc.\">NKE</a>):</b> FQ4 EPS of $0.76 <font color=\"green\">beats by $0.01</font>. Revenue of $6.7B (+7% Y/Y) <font color=\"green\">beats by $0.06B</font>. Shares  <font color=\"green\">+1.86%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"1111012\" data-linked=\"Nike (NYSE:NKE): FQ4 EPS of $0.76 beats by $0.01. Revenue of $6.7B (+7% Y/Y) beats by $0.06B....\" data-tweet=\"$NKE - Nike (NYSE:NKE): FQ4 EPS of $0.76 beats by $0.01. Revenue of $6.7B (+7% Y/Y) beats by $0.06B. Shares +1.86% AH. (PR) https://seekingalpha.com/news/1111012?source=tweet\" data-url=\"https://seekingalpha.com/news/1111012\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1111002\" data-ts=\"1372364223\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1111002\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oxygen Biotherapeutics (OXBT -2.7%) rebounds from a bigger hit earlier today after reporting a...</a></h4><p>Oxygen Biotherapeutics (OXBT <font color=\"red\">-2.7%</font>) rebounds from a bigger hit earlier today after reporting a full-year 2013 loss of $6.68 per share, more than half the 2012 loss $14.07 per share as operating expenses were reduced by 26% and net operating losses narrowed by 37%. Revenue came in at $1.1M, compared to $363,781 reported in 2012. Government grant revenue increased 263% Y/Y to $1.14M, due to progress on underlying studies for Oxycyte and the achievement of contractual milestones under the grant.</p><div class=\"tiny-share-widget\" data-id=\"1111002\" data-linked=\"Oxygen Biotherapeutics (OXBT -2.7%) rebounds from a bigger hit earlier today after reporting a...\" data-tweet=\"Oxygen Biotherapeutics (OXBT -2.7%) rebounds from a bigger hit earlier today after reporting a full-year 2013 loss of $6.68 per share, more than half the 2012 loss $14.07 per share as operating expenses were reduced by 26% and net operating losses narro... https://seekingalpha.com/news/1111002?source=tweet\" data-url=\"https://seekingalpha.com/news/1111002\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110952\" data-ts=\"1372363794\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAMP\" target=\"_blank\">CAMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110952\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CalAmp (NASDAQ:CAMP): Q1 EPS of $0.16 beats by $0.03. Revenue of $53.7M (+22.5% Y/Y) beats by...</a></h4><b>CalAmp (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CAMP\" title=\"CalAmp Corp.\">CAMP</a>):</b> Q1 EPS of $0.16 <font color=\"green\">beats by $0.03</font>. Revenue of $53.7M (+22.5% Y/Y) <font color=\"green\">beats by $1.29M</font>. Shares  <font color=\"green\">+2.36%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"1110952\" data-linked=\"CalAmp (NASDAQ:CAMP): Q1 EPS of $0.16 beats by $0.03. Revenue of $53.7M (+22.5% Y/Y) beats by...\" data-tweet=\"$CAMP - CalAmp (NASDAQ:CAMP): Q1 EPS of $0.16 beats by $0.03. Revenue of $53.7M (+22.5% Y/Y) beats by $1.29M. Shares +2.36% AH. (PR) https://seekingalpha.com/news/1110952?source=tweet\" data-url=\"https://seekingalpha.com/news/1110952\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110942\" data-ts=\"1372363516\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACN\" target=\"_blank\">ACN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110942\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Accenture (NYSE:ACN): FQ3 EPS of $1.14 beats by $0.01. Revenue of $7.2B misses by $0.22B. Shares...</a></h4><b>Accenture (NYSE:<a href=\"https://seekingalpha.com/symbol/ACN\" title=\"Accenture plc\">ACN</a>):</b> FQ3 EPS of $1.14 <font color=\"green\">beats by $0.01</font>. Revenue of $7.2B <font color=\"red\">misses by $0.22B</font>. Shares  <font color=\"red\">-3.9%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"1110942\" data-linked=\"Accenture (NYSE:ACN): FQ3 EPS of $1.14 beats by $0.01. Revenue of $7.2B misses by $0.22B. Shares...\" data-tweet=\"$ACN - Accenture (NYSE:ACN): FQ3 EPS of $1.14 beats by $0.01. Revenue of $7.2B misses by $0.22B. Shares -3.9% AH. (PR) https://seekingalpha.com/news/1110942?source=tweet\" data-url=\"https://seekingalpha.com/news/1110942\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110902\" data-ts=\"1372362849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ERF\" target=\"_blank\">ERF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110902\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enerplus (ERF +3.4%) agrees to sell ~C$80M of non-core assets in Canada to multiple parties but...</a></h4><p>Enerplus (<a href=\"https://seekingalpha.com/symbol/ERF\" title=\"Enerplus Corporation\">ERF</a> <font color=\"green\">+3.4%</font>) <a href=\"http://finance.yahoo.com/news/enerplus-sells-non-core-assets-100000523.html\" target=\"_blank\">agrees to sell</a> ~C$80M of non-core assets in Canada to multiple parties but maintains its 2013 production guidance, given strong operational performance to date. ERF expects annual production volumes will average ~85K boe/day, at  the high end of its previous guidance range.</p><div class=\"tiny-share-widget\" data-id=\"1110902\" data-linked=\"Enerplus (ERF +3.4%) agrees to sell ~C$80M of non-core assets in Canada to multiple parties but...\" data-tweet=\"$ERF - Enerplus (ERF +3.4%) agrees to sell ~C$80M of non-core assets in Canada to multiple parties but maintains its 2013 production guidance, given strong operational performance to date. ERF expects annual production volumes will average ~85K boe/day,... https://seekingalpha.com/news/1110902?source=tweet\" data-url=\"https://seekingalpha.com/news/1110902\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110882\" data-ts=\"1372362475\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAVB\" target=\"_blank\">NAVB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110882\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Navidea Biopharmaceuticals (NAVB +4.7%) trades up today after reporting results of its 2013...</a></h4><p>Navidea Biopharmaceuticals (<a href=\"https://seekingalpha.com/symbol/NAVB\" title=\"Navidea Biopharmaceuticals\">NAVB</a> <font color=\"green\">+4.7%</font>) trades up today after reporting results of its 2013 Annual Meeting of Stockholders held earlier today. <a href=\"https://seekingalpha.com/symbol/NAVB\" title=\"Navidea Biopharmaceuticals\">NAVB</a> made a series of presentations to shareholders highlighting Lymphoseek's U.S commercialization and indication expansion development activities, selection of a specialty pharma partner for its commercialization in Europe, and initiation of a pivotal NAV4694 Phase 3 registration study.</p><div class=\"tiny-share-widget\" data-id=\"1110882\" data-linked=\"Navidea Biopharmaceuticals (NAVB +4.7%) trades up today after reporting results of its 2013...\" data-tweet=\"$NAVB - Navidea Biopharmaceuticals (NAVB +4.7%) trades up today after reporting results of its 2013 Annual Meeting of Stockholders held earlier today. NAVB made a series of presentations to shareholders highlighting Lymphoseek&#39;s U.S commercialization an... https://seekingalpha.com/news/1110882?source=tweet\" data-url=\"https://seekingalpha.com/news/1110882\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110872\" data-ts=\"1372362346\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTCT\" target=\"_blank\">PTCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110872\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Recently public PTC Therapeutics (PTCT -15.9%) plummets after a negative article published at...</a></h4><p>Recently public PTC Therapeutics (<a href=\"https://seekingalpha.com/symbol/PTCT\" title=\"PTC Therapeutics\">PTCT</a> <font color=\"red\">-15.9%</font>) plummets after a <a href=\"http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1001593\" target=\"_blank\">negative article</a> published at PLOS Biology and a <a href=\"https://seekingalpha.com/article/1522772-the-evidence-builds-against-this-recent-biotech-ipo\" target=\"_blank\">subsequent piece</a> by SA contributor Prop Think question the efficacy of <a href=\"http://www.ptcbio.com/ataluren\" target=\"_blank\">ataluren</a>, the company's lead product candidate.</p><div class=\"tiny-share-widget\" data-id=\"1110872\" data-linked=\"Recently public PTC Therapeutics (PTCT -15.9%) plummets after a negative article published at...\" data-tweet=\"$PTCT - Recently public PTC Therapeutics (PTCT -15.9%) plummets after a negative article published at PLOS Biology and a subsequent piece by SA contributor Prop Think question the efficacy of ataluren, the company&#39;s lead product candidate. https://seekingalpha.com/news/1110872?source=tweet\" data-url=\"https://seekingalpha.com/news/1110872\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110822\" data-ts=\"1372361436\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VVUS\" target=\"_blank\">VVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110822\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivus (VVUS -3.7%) slips today after saying it&#39;s mailed a letter to stockholders advising them...</a></h4><p>Vivus (<a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> <font color=\"red\">-3.7%</font>) slips today after saying it's mailed a letter to stockholders advising them to vote against First Manhattan's slate of directors, saying \"A vote for FMC and Sam Colin  equals increased RISK.\" That risk, the company says, includes threatening ongoing Qsymia commercialization efforts, as well as jeopardizing discussions <a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> is currently having with large pharmaceutical companies to increase primary care physician outreach. Read the full letter here: <a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> Letter to Stockholders.</p><div class=\"tiny-share-widget\" data-id=\"1110822\" data-linked=\"Vivus (VVUS -3.7%) slips today after saying it&#39;s mailed a letter to stockholders advising them...\" data-tweet=\"$VVUS - Vivus (VVUS -3.7%) slips today after saying it&#39;s mailed a letter to stockholders advising them to vote against First Manhattan&#39;s slate of directors, saying &quot;A vote for FMC and Sam Colin equals increased RISK.&quot; That risk, the company says, includ... https://seekingalpha.com/news/1110822?source=tweet\" data-url=\"https://seekingalpha.com/news/1110822\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110812\" data-ts=\"1372360908\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HQCL\" target=\"_blank\">HQCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110812\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hanwha SolarOne (HSOL +12.2%) soars after securing a $100M term loan facility from the...</a></h4><p>Hanwha SolarOne (HSOL <font color=\"green\">+12.2%</font>) soars after securing a $100M term loan facility from the Export-Import Bank of Korea at LIBOR plus 199 basis points. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1110812\" data-linked=\"Hanwha SolarOne (HSOL +12.2%) soars after securing a $100M term loan facility from the...\" data-tweet=\"$HQCL - Hanwha SolarOne (HSOL +12.2%) soars after securing a $100M term loan facility from the Export-Import Bank of Korea at LIBOR plus 199 basis points. (PR) https://seekingalpha.com/news/1110812?source=tweet\" data-url=\"https://seekingalpha.com/news/1110812\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110772\" data-ts=\"1372360013\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTLA\" target=\"_blank\">PTLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110772\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Portola Pharmaceuticals (PTLA +10.1%) moves up after saying late yesterday that it had entered...</a></h4><p>Portola Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/PTLA\" title=\"Portola Pharmaceuticals\">PTLA</a> <font color=\"green\">+10.1%</font>) moves up after saying late yesterday that it had entered into a clinical collaboration agreement with Daiichi Sankyo (<a href=\"https://seekingalpha.com/symbol/DSNKY\" title=\"Daiichi Sankyo Co., Ltd. ADR\">OTCPK:DSNKY</a>) to conduct a Phase 2 study of its investigational Factor Xa inhibitor antidote PRT4445, or andexanet alfa. The study will at several different doses to reverse the anticoagulant effects of Daiichi Sankyo's edoxaban in healthy volunteers.</p><div class=\"tiny-share-widget\" data-id=\"1110772\" data-linked=\"Portola Pharmaceuticals (PTLA +10.1%) moves up after saying late yesterday that it had entered...\" data-tweet=\"$PTLA $PTLA $DSNKY - Portola Pharmaceuticals (PTLA +10.1%) moves up after saying late yesterday that it had entered into a clinical collaboration agreement with Daiichi Sankyo (OTCPK:DSNKY) to conduct a Phase 2 study of its investigational Factor Xa inh... https://seekingalpha.com/news/1110772?source=tweet\" data-url=\"https://seekingalpha.com/news/1110772\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110702\" data-ts=\"1372359210\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APD\" target=\"_blank\">APD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110702\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML downgrades Air Products (APD -2.9%) to Underperform from Neutral in a valuation call, as...</a></h4><p>BAML <a href=\"http://www.forbes.com/sites/marketnewsvideo/2013/06/27/analyst-moves-apd-crr\" target=\"_blank\">downgrades</a> Air Products (<a href=\"https://seekingalpha.com/symbol/APD\" title=\"Air Products and Chemicals, Inc.\">APD</a> <font color=\"red\">-2.9%</font>) to Underperform from Neutral in a valuation call, as the stock has pushed through the firm\u2019s $90 price target, making it less attractive on a risk/reward basis. The tone has been less enthusiastic in recent quarterly reports, with management trimming guidance and revenue often missing forecasts.</p><div class=\"tiny-share-widget\" data-id=\"1110702\" data-linked=\"BAML downgrades Air Products (APD -2.9%) to Underperform from Neutral in a valuation call, as...\" data-tweet=\"$APD - BAML downgrades Air Products (APD -2.9%) to Underperform from Neutral in a valuation call, as the stock has pushed through the firm\u2019s $90 price target, making it less attractive on a risk/reward basis. The tone has been less enthusiastic in recen... https://seekingalpha.com/news/1110702?source=tweet\" data-url=\"https://seekingalpha.com/news/1110702\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110692\" data-ts=\"1372358979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110692\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Volatile Alcatel-Lucent (ALU +7.5%) is among the day&#39;s big winners; today&#39;s gains come 3 days...</a></h4><p>Volatile Alcatel-Lucent (ALU <font color=\"green\">+7.5%</font>) is among the day's big winners; today's gains come 3 days after shares fell 7% during a market rout. Alcatel announced overnight #3 Italian mobile carrier Wind (22M mobile subs + 3M wireline subs) has tapped the company to provide a \"network transformation solution\" that includes its <a href=\"http://www.alcatel-lucent.com/solutions/agile-optical-networking/components#managed\" target=\"_blank\">100G optical transmission systems</a>, related optical switches, and <a href=\"http://www.alcatel-lucent.com/products/7750-service-router/details\" target=\"_blank\">7750 edge router</a>.</p><div class=\"tiny-share-widget\" data-id=\"1110692\" data-linked=\"Volatile Alcatel-Lucent (ALU +7.5%) is among the day&#39;s big winners; today&#39;s gains come 3 days...\" data-tweet=\"$NOK - Volatile Alcatel-Lucent (ALU +7.5%) is among the day&#39;s big winners; today&#39;s gains come 3 days after shares fell 7% during a market rout. Alcatel announced overnight #3 Italian mobile carrier Wind (22M mobile subs + 3M wireline subs) has tapped th... https://seekingalpha.com/news/1110692?source=tweet\" data-url=\"https://seekingalpha.com/news/1110692\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110682\" data-ts=\"1372358850\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSK\" target=\"_blank\">GSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110682\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GlaxoSmithKline (GSK +0.4%) receives &quot;verbal notification&quot; from the FDA that its DMD treatment...</a></h4><p>GlaxoSmithKline (<a href=\"https://seekingalpha.com/symbol/GSK\" title=\"GlaxoSmithKline\">GSK</a> <font color=\"green\">+0.4%</font>) receives \"<a target=\"_blank\" href=\"http://www.nasdaq.com/article/glaxosmithklines-drisapersen-to-get-breakthrough-therapy-designation-20130627-00629\">verbal notification</a>\" from the FDA that its DMD treatment Drisapersen has been granted Breakthrough Therapy designation. This is good news for Prosensa, which has licensed the development of the drug to GSK and potentially bad news for Sarepta (<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a> <font color=\"red\">-3.8%</font>) whose Eteplirsen is <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1107782\">widely expected</a> to receive the designation for the same indication. Deutsche \u2014 which <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1107372\">weighed in yesterday</a> on the issue \u2014 says SRPT's treatment <a target=\"_blank\" href=\"http://www.streetinsider.com/Analyst+Comments/Sarepta%27s+%28SRPT%29+Eteplirsen+Can+Still+Get+Breakthrough+for+DMD%2C+Deutsche+Bank+Says+%28GSK%29/8455869.html\">could still get</a> an FDA nod.</p><div class=\"tiny-share-widget\" data-id=\"1110682\" data-linked=\"GlaxoSmithKline (GSK +0.4%) receives &quot;verbal notification&quot; from the FDA that its DMD treatment...\" data-tweet=\"$GSK $GSK $SRPT - GlaxoSmithKline (GSK +0.4%) receives &quot;verbal notification&quot; from the FDA that its DMD treatment Drisapersen has been granted Breakthrough Therapy designation. This is good news for Prosensa, which has licensed the development of the dru... https://seekingalpha.com/news/1110682?source=tweet\" data-url=\"https://seekingalpha.com/news/1110682\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110672\" data-ts=\"1372358672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTLA\" target=\"_blank\">PTLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110672\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Portola Pharmaceuticals (PTLA +10.1%) moves up after saying late yesterday that it had entered...</a></h4><p>Portola Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/PTLA\" title=\"Portola Pharmaceuticals\">PTLA</a> <font color=\"green\">+10.1%</font>) moves up after saying late yesterday that it had entered into a clinical collaboration agreement with Daiichi Sankyo (<a href=\"https://seekingalpha.com/symbol/DSNKY\" title=\"Daiichi Sankyo Co., Ltd. ADR\">OTCPK:DSNKY</a>) to conduct a Phase 2 study of its investigational Factor Xa inhibitor antidote PRT4445, or andexanet alfa. The study will at several different doses to reverse the anticoagulant effects of Daiichi Sankyo's oral direct Factor Xa inhibitor edoxaban in healthy volunteers.</p><div class=\"tiny-share-widget\" data-id=\"1110672\" data-linked=\"Portola Pharmaceuticals (PTLA +10.1%) moves up after saying late yesterday that it had entered...\" data-tweet=\"$PTLA $PTLA $DSNKY - Portola Pharmaceuticals (PTLA +10.1%) moves up after saying late yesterday that it had entered into a clinical collaboration agreement with Daiichi Sankyo (OTCPK:DSNKY) to conduct a Phase 2 study of its investigational Factor Xa inh... https://seekingalpha.com/news/1110672?source=tweet\" data-url=\"https://seekingalpha.com/news/1110672\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110642\" data-ts=\"1372358115\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNC\" target=\"_blank\">GNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110642\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GNC Holdings (GNC -3%) drops, perhaps on a report out of ITG research suggesting Q2 revenue may...</a></h4><p>GNC Holdings (<a href=\"https://seekingalpha.com/symbol/GNC\" title=\"GNC Holdings, Inc.\">GNC</a> <font color=\"red\">-3%</font>) drops, perhaps on a report out of ITG research suggesting Q2 revenue <a href=\"http://www.streetinsider.com/Analyst+Comments/GNC+%28GNC%29+Declines%3B+Member+Pricing+Could+be+Revenue+Drag/8456302.html\" target=\"_blank\">may come up short</a> thanks to membership pricing concerns.</p><div class=\"tiny-share-widget\" data-id=\"1110642\" data-linked=\"GNC Holdings (GNC -3%) drops, perhaps on a report out of ITG research suggesting Q2 revenue may...\" data-tweet=\"$GNC - GNC Holdings (GNC -3%) drops, perhaps on a report out of ITG research suggesting Q2 revenue may come up short thanks to membership pricing concerns. https://seekingalpha.com/news/1110642?source=tweet\" data-url=\"https://seekingalpha.com/news/1110642\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110632\" data-ts=\"1372357795\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEU\" target=\"_blank\">LEU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110632\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">USEC (USU -7.8%) shareholders approve a 1-for-25 reverse stock split effective after the close...</a></h4><p>USEC (USU <font color=\"red\">-7.8%</font>) shareholders approve a 1-for-25 reverse stock split effective after the close on July 1, a move to enable USEC to regain NYSE continued listing requirements and broaden the appeal of the stock to investors.</p><div class=\"tiny-share-widget\" data-id=\"1110632\" data-linked=\"USEC (USU -7.8%) shareholders approve a 1-for-25 reverse stock split effective after the close...\" data-tweet=\"$LEU - USEC (USU -7.8%) shareholders approve a 1-for-25 reverse stock split effective after the close on July 1, a move to enable USEC to regain NYSE continued listing requirements and broaden the appeal of the stock to investors. https://seekingalpha.com/news/1110632?source=tweet\" data-url=\"https://seekingalpha.com/news/1110632\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110612\" data-ts=\"1372357337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CERE\" target=\"_blank\">CERE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110612\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Cere (CERE +29.4%) soar today on no specific news driver. Although the company says it...</a></h4><p>Shares of Cere (<a href=\"https://seekingalpha.com/symbol/CERE\" title=\"Ceres, Inc.\">CERE</a> <font color=\"green\">+29.4%</font>) soar today on no specific news driver. Although the company says it isn't aware of any catalyst, it's worth noting that <a href=\"https://seekingalpha.com/symbol/CERE\" title=\"Ceres, Inc.\">CERE</a> is a biotech company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products, and one of the <a href=\"http://www.showtimesdaily.com/act-expo-2013-news-coverage\" target=\"_blank\">presentations yesterday</a> at the ACT Expo focused on ways to cut petroleum use over the next 20 years.</p><div class=\"tiny-share-widget\" data-id=\"1110612\" data-linked=\"Shares of Cere (CERE +29.4%) soar today on no specific news driver. Although the company says it...\" data-tweet=\"$CERE - Shares of Cere (CERE +29.4%) soar today on no specific news driver. Although the company says it isn&#39;t aware of any catalyst, it&#39;s worth noting that CERE is a biotech company that markets seeds for energy crops used in the production of renewabl... https://seekingalpha.com/news/1110612?source=tweet\" data-url=\"https://seekingalpha.com/news/1110612\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110602\" data-ts=\"1372356947\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSIQ\" target=\"_blank\">CSIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110602\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Volatile solar stocks are rallying today (TAN +1.8%) after taking it on the chin earlier this...</a></h4><p>Volatile solar stocks are rallying today (<a href=\"https://seekingalpha.com/symbol/TAN\" title=\"Invesco Solar Portfolio ETF\">TAN</a> <font color=\"green\">+1.8%</font>) after taking it on the chin <a href=\"https://seekingalpha.com/currents/post/1102382\" target=\"_blank\">earlier this week</a> thanks to Chinese macro concerns. In addition to GT Advanced (<a href=\"https://seekingalpha.com/currents/post/1109752\" target=\"_blank\">previous</a>), big winners include Canadian Solar (<a href=\"https://seekingalpha.com/symbol/CSIQ\" title=\"Canadian Solar Inc.\">CSIQ</a> <font color=\"green\">+9.3%</font>), JinkoSolar (<a href=\"https://seekingalpha.com/symbol/JKS\" title=\"JinkoSolar Holding Co., Ltd.\">JKS</a> <font color=\"green\">+10.4%</font>), LDK (<a href=\"https://seekingalpha.com/symbol/LDK\" title=\"LDK Solar Co., Ltd.\">LDK</a> <font color=\"green\">+4.5%</font>), and Trina (<a href=\"https://seekingalpha.com/symbol/TSL\" title=\"Trina Solar Limited\">TSL</a> <font color=\"green\">+4.4%</font>). CSIQ is now <font color=\"green\">up 23%</font> over the last two days, after jumping yesterday in response to its <a href=\"https://seekingalpha.com/currents/post/1107472\" target=\"_blank\">Samsung deal</a>.</p><div class=\"tiny-share-widget\" data-id=\"1110602\" data-linked=\"Volatile solar stocks are rallying today (TAN +1.8%) after taking it on the chin earlier this...\" data-tweet=\"$CSIQ $TAN $CSIQ - Volatile solar stocks are rallying today (TAN +1.8%) after taking it on the chin earlier this week thanks to Chinese macro concerns. In addition to GT Advanced (previous), big winners include Canadian Solar (CSIQ +9.3%), JinkoSolar (J... https://seekingalpha.com/news/1110602?source=tweet\" data-url=\"https://seekingalpha.com/news/1110602\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110582\" data-ts=\"1372356502\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/N\" target=\"_blank\">N</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110582\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">William Blair starts coverage on NetSuite (N +3.8%) with an Outperform, sending shares above $92...</a></h4><p>William Blair starts coverage on NetSuite (<a href=\"https://seekingalpha.com/symbol/N\" title=\"NetSuite Inc.\">N</a> <font color=\"green\">+3.8%</font>) with an Outperform, sending shares above $92 a day after the company announced a <a href=\"https://seekingalpha.com/currents/post/1108582\" target=\"_blank\">cloud ERP/HR software tie-up</a> with Oracle aimed at mid-sized businesses. Several analysts have <a href=\"https://twitter.com/ScalpIdeas/status/350245361492824065\" target=\"_blank\">praised the deal</a>, generally for increasing NetSuite's distribution/addressable market size.</p><div class=\"tiny-share-widget\" data-id=\"1110582\" data-linked=\"William Blair starts coverage on NetSuite (N +3.8%) with an Outperform, sending shares above $92...\" data-tweet=\"$N - William Blair starts coverage on NetSuite (N +3.8%) with an Outperform, sending shares above $92 a day after the company announced a cloud ERP/HR software tie-up with Oracle aimed at mid-sized businesses. Several analysts have praised the deal, gen... https://seekingalpha.com/news/1110582?source=tweet\" data-url=\"https://seekingalpha.com/news/1110582\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110522\" data-ts=\"1372355141\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPRT\" target=\"_blank\">WPRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110522\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Westport Innovations (WPRT +8.9%) rise again today, pushing the shares up 14% over the...</a></h4><p>Shares of Westport Innovations (<a href=\"https://seekingalpha.com/symbol/WPRT\" title=\"Westport Fuel Systems, Inc.\">WPRT</a> <font color=\"green\">+8.9%</font>) rise again today, pushing the shares up 14% over the past two sessions. Today's rise might be attributed to <a href=\"https://twitter.com/CainDeanna\" target=\"_blank\">upbeat comments</a> made in a keynote speech by <a href=\"https://seekingalpha.com/symbol/UPS\" title=\"United Parcel Service, Inc.\">UPS</a> at the ACT Expo in Washington, DC. The delivery giant commited earlier this year to <a href=\"https://seekingalpha.com/market_currents/post/656251\" target=\"_blank\">using liquefied natural gas trucks</a>, powered by Westport HD Systems, in interstate operations for its Ontario, California to Las Vegas, Nevada route.</p><div class=\"tiny-share-widget\" data-id=\"1110522\" data-linked=\"Shares of Westport Innovations (WPRT +8.9%) rise again today, pushing the shares up 14% over the...\" data-tweet=\"$WPRT $WPRT $UPS - Shares of Westport Innovations (WPRT +8.9%) rise again today, pushing the shares up 14% over the past two sessions. Today&#39;s rise might be attributed to upbeat comments made in a keynote speech by UPS at the ACT Expo in Washington, DC.... https://seekingalpha.com/news/1110522?source=tweet\" data-url=\"https://seekingalpha.com/news/1110522\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110512\" data-ts=\"1372355089\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHTR\" target=\"_blank\">CHTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110512\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cable stock frenzy: Shares of Time Warner Cable (TWC +7.8%) spike higher off of a Bloomberg...</a></h4>Cable stock frenzy: Shares of Time Warner Cable (TWC <font color=\"green\">+7.8%</font>) spike higher off of a <a target=\"_blank\" href=\"https://twitter.com/sherman4949/status/350301379832713216\">Bloomberg headline</a> indicating Liberty Media (LMCA <font color=\"green\">+2.5%</font>) is interesting in making a bid. Cablevision (<a href='https://seekingalpha.com/symbol/CVC' title='Cablevision Systems Corporation'>CVC</a> <font color=\"green\">+7.8%</font>) and Charter Communications (<a href='https://seekingalpha.com/symbol/CHTR' title='Charter Communications, Inc.'>CHTR</a> <font color=\"green\">+5.9%</font>) are also on the move.<div class=\"tiny-share-widget\" data-id=\"1110512\" data-linked=\"Cable stock frenzy: Shares of Time Warner Cable (TWC +7.8%) spike higher off of a Bloomberg...\" data-tweet=\"$CHTR $CHTR $FWONA - Cable stock frenzy: Shares of Time Warner Cable (TWC +7.8%) spike higher off of a Bloomberg headline indicating Liberty Media (LMCA +2.5%) is interesting in making a bid. Cablevision (CVC +7.8%) and Charter Communications (CHTR +5.9... https://seekingalpha.com/news/1110512?source=tweet\" data-url=\"https://seekingalpha.com/news/1110512\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110502\" data-ts=\"1372354228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLD\" target=\"_blank\">GLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110502\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold&#39;s (GLD -0.9%) tumbled to new bear market lows in the last few minutes, now just a few...</a></h4>Gold's (<a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a> <font color='red'>-0.9%</font>) tumbled to new bear market lows in the <a href=\"http://finviz.com/futures_charts.ashx?t=GC&amp;p=m5\" target=\"_blank\">last few minutes</a>, now just a few dollars above $1,200 per ounce. When all else fails, check with the technicians - one isn't <a href=\"http://allstarcharts.com/if-this-is-the-gold-bottom-its-totally-random/\" target=\"_blank\">seeing support</a> until the $1,150 area.<div class=\"tiny-share-widget\" data-id=\"1110502\" data-linked=\"Gold&#39;s (GLD -0.9%) tumbled to new bear market lows in the last few minutes, now just a few...\" data-tweet=\"$GLD $GLD $IAU - Gold&#39;s (GLD -0.9%) tumbled to new bear market lows in the last few minutes, now just a few dollars above $1,200 per ounce. When all else fails, check with the technicians - one isn&#39;t seeing support until the $1,150 area. https://seekingalpha.com/news/1110502?source=tweet\" data-url=\"https://seekingalpha.com/news/1110502\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110432\" data-ts=\"1372352009\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEGN\" target=\"_blank\">AEGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110432\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aegion (AEGN +2.6%) gains after saying its Insituform Technologies unit has been awarded a $16M...</a></h4><p>Aegion (<a href=\"https://seekingalpha.com/symbol/AEGN\" title=\"Aegion Corporation\">AEGN</a> <font color=\"green\">+2.6%</font>) gains after saying its Insituform Technologies unit has been awarded a $16M contract from the City of Baltimore, Maryland to install over 170K feet of its small- and medium-diameter pipe in wastewater pipelines located in urban areas in the north and east portions of the city. Work is expected to begin in Q3, and will take approximately 16 months to complete. Since last December, the City of Baltimore has awarded Insituform over $46M in contracts.</p><div class=\"tiny-share-widget\" data-id=\"1110432\" data-linked=\"Aegion (AEGN +2.6%) gains after saying its Insituform Technologies unit has been awarded a $16M...\" data-tweet=\"$AEGN - Aegion (AEGN +2.6%) gains after saying its Insituform Technologies unit has been awarded a $16M contract from the City of Baltimore, Maryland to install over 170K feet of its small- and medium-diameter pipe in wastewater pipelines located in urb... https://seekingalpha.com/news/1110432?source=tweet\" data-url=\"https://seekingalpha.com/news/1110432\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110412\" data-ts=\"1372351623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGRP\" target=\"_blank\">SGRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110412\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers: SGRP +33%. CERE +32%. GTAT +15%. TWER +13%. ENPH +12%. HSOL +12%. BXE...</a></h4><b>Midday top 10 gainers:</b> <a href='https://seekingalpha.com/symbol/SGRP' title='SPAR Group, Inc.'>SGRP</a> <font color=\"green\">+33%</font>. <a href='https://seekingalpha.com/symbol/CERE' title='Ceres, Inc.'>CERE</a> <font color=\"green\">+32%</font>. GTAT <font color=\"green\">+15%</font>. <a href='https://seekingalpha.com/symbol/TWER-OLD' title='Towerstream Corporation'>TWER</a> <font color=\"green\">+13%</font>. <a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a> <font color=\"green\">+12%</font>. HSOL <font color=\"green\">+12%</font>. <a href='https://seekingalpha.com/symbol/BXE' title='Bellatrix Exploration Ltd'>BXE</a> <font color=\"green\">+11%</font>. <a href='https://seekingalpha.com/symbol/IVAC' title='Intevac, Inc.'>IVAC</a> <font color=\"green\">+11%</font>. <a href='https://seekingalpha.com/symbol/MEET' title='The Meet Group, Inc.'>MEET</a> <font color=\"green\">+10%</font>. <a href='https://seekingalpha.com/symbol/BIOF' title='BioFuel Energy Corp.'>BIOF</a> <font color=\"green\">+10%</font>. <br /><b>Midday top 10 Losers:</b> NBG <font color=\"red\">-22%</font>. PPHM <font color=\"red\">-21%</font>. <a href='https://seekingalpha.com/symbol/DCIX' title='Diana Containerships Inc.'>DCIX</a> <font color=\"red\">-9%</font>. <a href='https://seekingalpha.com/symbol/AMCC' title='Applied Micro Circuits Corporation'>AMCC</a> <font color=\"red\">-9%</font>. <a href='https://seekingalpha.com/symbol/WHX' title='Whiting USA Trust'>WHX</a> <font color=\"red\">-9%</font>. <a href='https://seekingalpha.com/symbol/JCTCF' title='Jewett-Cameron Trading Company'>JCTCF</a> <font color=\"red\">-8%</font>. <a href='https://seekingalpha.com/symbol/SIR' title='Select Income REIT'>SIR</a> <font color=\"red\">-8%</font>. <a href='https://seekingalpha.com/symbol/AMS' title='American Shared Hospital Services'>AMS</a> <font color=\"red\">-7%</font>. <a href='https://seekingalpha.com/symbol/CRMD' title='CorMedix Inc.'>CRMD</a> <font color=\"red\">-7%</font>. <a href='https://seekingalpha.com/symbol/SINO' title='Sino-Global Shipping America, Ltd.'>SINO</a> <font color=\"red\">-7%</font>.<div class=\"tiny-share-widget\" data-id=\"1110412\" data-linked=\"Midday top 10 gainers: SGRP +33%. CERE +32%. GTAT +15%. TWER +13%. ENPH +12%. HSOL +12%. BXE...\" data-tweet=\"$SGRP $SGRP $CERE - Midday top 10 gainers: SGRP +33%. CERE +32%. GTAT +15%. TWER +13%. ENPH +12%. HSOL +12%. BXE +11%. IVAC +11%. MEET +10%. BIOF +10%. Midday top 10 Losers: NBG -22%. PPHM -21%. DCIX -9%. AMCC -9%. WHX -9%. JCTCF -8%. SIR -8%. AMS -7%. ... https://seekingalpha.com/news/1110412?source=tweet\" data-url=\"https://seekingalpha.com/news/1110412\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110372\" data-ts=\"1372350037\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEN\" target=\"_blank\">LEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110372\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lennar (LEN +3%) gets a boost from an upgrade to Buy at CRT Capital with a price target of...</a></h4><p>Lennar (<a href=\"https://seekingalpha.com/symbol/LEN\" title=\"Lennar Corporation\">LEN</a> <font color=\"green\">+3%</font>) gets a boost from an <a href=\"http://www.streetinsider.com/Upgrades/CRT+Capital+Upgrades+Lennar+%28LEN%29+to+Buy/8454234.html\" target=\"_blank\">upgrade to Buy</a> at CRT Capital with a price target of $48.50. Just yesterday, Goldman Sachs <a href=\"http://www.streetinsider.com/Analyst+Comments/Lennar+%28LEN%29+Investors+Overly+Focused+on+Interest+Rates%2C+Says+Goldman/8451066.html\" target=\"_blank\">upped its price target</a> on the shares following a <a href=\"https://seekingalpha.com/market_currents/post/1103502\" target=\"_blank\">solid FQ2 earnings report</a>, citing better margin assumptions.</p><div class=\"tiny-share-widget\" data-id=\"1110372\" data-linked=\"Lennar (LEN +3%) gets a boost from an upgrade to Buy at CRT Capital with a price target of...\" data-tweet=\"$LEN - Lennar (LEN +3%) gets a boost from an upgrade to Buy at CRT Capital with a price target of $48.50. Just yesterday, Goldman Sachs upped its price target on the shares following a solid FQ2 earnings report, citing better margin assumptions. https://seekingalpha.com/news/1110372?source=tweet\" data-url=\"https://seekingalpha.com/news/1110372\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110362\" data-ts=\"1372349479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGRP\" target=\"_blank\">SGRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110362\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Spar Group (SGRP +38.8%) spike on heavy volume. In what now looks like a particularly...</a></h4><p>Shares of Spar Group (<a href=\"https://seekingalpha.com/symbol/SGRP\" title=\"SPAR Group, Inc.\">SGRP</a> <font color=\"green\">+38.8%</font>) spike on heavy volume. In what now looks like a particularly prescient call, SA Pro contributor Igor Novgorodtsev <a href=\"https://seekingalpha.com/article/1514142-spar-group-a-growth-company-at-a-still-very-reasonable-price\" target=\"_blank\">recommended the stock</a> last week, noting that it \"likely won't stay cheap for too long.\"</p><div class=\"tiny-share-widget\" data-id=\"1110362\" data-linked=\"Shares of Spar Group (SGRP +38.8%) spike on heavy volume. In what now looks like a particularly...\" data-tweet=\"$SGRP - Shares of Spar Group (SGRP +38.8%) spike on heavy volume. In what now looks like a particularly prescient call, SA Pro contributor Igor Novgorodtsev recommended the stock last week, noting that it &quot;likely won&#39;t stay cheap for too long.&quot; https://seekingalpha.com/news/1110362?source=tweet\" data-url=\"https://seekingalpha.com/news/1110362\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110282\" data-ts=\"1372348756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PETX\" target=\"_blank\">PETX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110282\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aratana Therapeutics (NASDAQ:PETX) trades higher in its debut, currently over $8 after pricing...</a></h4><p>Aratana Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PETX\" title=\"Aratana Therapeutics\">PETX</a>) <a href=\"http://www.streetinsider.com/IPOs/Aratana+Therapeutics+%28PETX%29+IPO+Opens+Higher/8455621.html\" target=\"_blank\">trades higher</a> in its debut, currently over $8 after pricing its 5,750,000 share IPO at $6 per share and opening this morning at $7. The company is a development-stage biopharmaceutical company focused on prescription medications for pets. Stifel and Lazard Capital Markets are co-leads for the offering.</p><div class=\"tiny-share-widget\" data-id=\"1110282\" data-linked=\"Aratana Therapeutics (NASDAQ:PETX) trades higher in its debut, currently over $8 after pricing...\" data-tweet=\"$PETX - Aratana Therapeutics (NASDAQ:PETX) trades higher in its debut, currently over $8 after pricing its 5,750,000 share IPO at $6 per share and opening this morning at $7. The company is a development-stage biopharmaceutical company focused on prescr... https://seekingalpha.com/news/1110282?source=tweet\" data-url=\"https://seekingalpha.com/news/1110282\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110272\" data-ts=\"1372348652\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNX\" target=\"_blank\">CNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110272\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consol (CNX +2.1%) claws back from YTD&amp;nbsp;lows exacerbated by Pres. Obama&#39;s climate change...</a></h4><p>Consol (<a href=\"https://seekingalpha.com/symbol/CNX\" title=\"CNX Resources Corporation\">CNX</a> <font color=\"green\">+2.1%</font>) claws back from YTD lows exacerbated by Pres. Obama's climate change speech, as CNX <a href=\"http://online.wsj.com/article/SB10001424127887323689204578569940685984374.html\" target=\"_blank\">would stand to benefit from regulations favoring natural gas</a>, which produces fewer carbon emissions than coal. \"We'll be able to supply our customers with natural gas if that's the route [the administration] chooses to go,\" a VP tells <em>WSJ</em>. CNX currently gets ~14% of its revenue from nat gas production. (<a href=\"http://www.bizjournals.com/pittsburgh/blog/morning-edition/2013/06/report-consol-best-positioned-with.html\" target=\"_blank\">also</a>)</p><div class=\"tiny-share-widget\" data-id=\"1110272\" data-linked=\"Consol (CNX +2.1%) claws back from YTD lows exacerbated by Pres. Obama&#39;s climate change speech,...\" data-tweet=\"$CNX - Consol (CNX +2.1%) claws back from YTD lows exacerbated by Pres. Obama&#39;s climate change speech, as CNX would stand to benefit from regulations favoring natural gas, which produces fewer carbon emissions than coal. &quot;We&#39;ll be able to supply our cus... https://seekingalpha.com/news/1110272?source=tweet\" data-url=\"https://seekingalpha.com/news/1110272\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110242\" data-ts=\"1372348566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNG\" target=\"_blank\">UNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110242\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas (UNG -4.5%) plummets following a larger than expected inventory build as well as a...</a></h4>Natural gas (<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a> <font color='red'>-4.5%</font>) plummets following a larger than expected<a href=\"https://seekingalpha.com/currents/post/1109982\" target=\"_blank\"> inventory build</a> as well as a continued outlook for moderate summer temperatures in the Northeast. Total stocks now stand at 2.533T cubic feet, off 522B from a year ago, and 31B below the 5-year average.<div class=\"tiny-share-widget\" data-id=\"1110242\" data-linked=\"Natural gas (UNG -4.5%) plummets following a larger than expected inventory build as well as a...\" data-tweet=\"$UNG $GAZ-OLD $UNL - Natural gas (UNG -4.5%) plummets following a larger than expected inventory build as well as a continued outlook for moderate summer temperatures in the Northeast. Total stocks now stand at 2.533T cubic feet, off 522B from a year ag... https://seekingalpha.com/news/1110242?source=tweet\" data-url=\"https://seekingalpha.com/news/1110242\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110222\" data-ts=\"1372347825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENMD\" target=\"_blank\">ENMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110222\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EntreMed (ENMD +4.4%) pops after submitting a new drug global clinical trial application with...</a></h4><p>EntreMed (<a href=\"https://seekingalpha.com/symbol/ENMD\" title=\"EntreMed, Inc.\">ENMD</a> <font color=\"green\">+4.4%</font>) pops after submitting a new drug global clinical trial application with the China Food and Drug Administration for its oncology drug candidate, ENMD-2076. The purpose of the application is to expand Phase 2 clinical trials in advanced/metastatic sarcoma currently being conducted at Princess Margaret Hospital. CEO Dr. Ken Ren notes that expanding trials into China will enable the <a href=\"https://seekingalpha.com/symbol/ENMD\" title=\"EntreMed, Inc.\">ENMD</a> to explore the drug's potential at an accelerated pace, due to faster patient recruitment and lower study costs.</p><div class=\"tiny-share-widget\" data-id=\"1110222\" data-linked=\"EntreMed (ENMD +4.4%) pops after submitting a new drug global clinical trial application with...\" data-tweet=\"$ENMD - EntreMed (ENMD +4.4%) pops after submitting a new drug global clinical trial application with the China Food and Drug Administration for its oncology drug candidate, ENMD-2076. The purpose of the application is to expand Phase 2 clinical trials ... https://seekingalpha.com/news/1110222?source=tweet\" data-url=\"https://seekingalpha.com/news/1110222\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110212\" data-ts=\"1372347765\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPI\" target=\"_blank\">LPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110212\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Laredo Petroleum (LPI +3.8%) is initiated at Brean Capital with a Buy rating and $27 price...</a></h4><p>Laredo Petroleum (<a href=\"https://seekingalpha.com/symbol/LPI\" title=\"Laredo Petroleum Holdings, Inc.\">LPI</a> <font color=\"green\">+3.8%</font>) is initiated at Brean Capital with a <a href=\"http://www.streetinsider.com/New+Coverage/Brean+Capital+Starts+Laredo+Petroleum+%28LPI%29+at+Buy%3B+Accelerating+Wolfcamp+Shale+Development/8454065.html\" target=\"_blank\">Buy rating</a> and $27 price target, which sees improving results from the horizontal Wolfcamp Shale play in the  Midland Basin as the biggest driver for share-price appreciation in 2013-14. The firm also sees further delineation and de-risking of LPI's Midland Basin acreage as a catalyst.</p><div class=\"tiny-share-widget\" data-id=\"1110212\" data-linked=\"Laredo Petroleum (LPI +3.8%) is initiated at Brean Capital with a Buy rating and $27 price...\" data-tweet=\"$LPI - Laredo Petroleum (LPI +3.8%) is initiated at Brean Capital with a Buy rating and $27 price target, which sees improving results from the horizontal Wolfcamp Shale play in the Midland Basin as the biggest driver for share-price appreciation in 201... https://seekingalpha.com/news/1110212?source=tweet\" data-url=\"https://seekingalpha.com/news/1110212\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110202\" data-ts=\"1372347544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACAS\" target=\"_blank\">ACAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110202\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Capital (ACAS +2.6%) logs a big gain after last night&#39;s announcement of a continued...</a></h4><p>American Capital (<a href=\"https://seekingalpha.com/symbol/ACAS\" title=\"American Capital\">ACAS</a> <font color=\"green\">+2.6%</font>) logs a big gain after last night's announcement of a <a href=\"https://seekingalpha.com/currents/post/1108342\" target=\"_blank\">continued fast pace</a> of buybacks in Q2. Illustrating the quick decline in the shares over the last 2 months, the average price of purchases was more than 10% over today's price, and 3.2% less than the average buyback price in Q1. March 31 NAV was $19.04, more than 50% above the stock price this morning.</p><div class=\"tiny-share-widget\" data-id=\"1110202\" data-linked=\"American Capital (ACAS +2.6%) logs a big gain after last night&#39;s announcement of a continued...\" data-tweet=\"$ACAS - American Capital (ACAS +2.6%) logs a big gain after last night&#39;s announcement of a continued fast pace of buybacks in Q2. Illustrating the quick decline in the shares over the last 2 months, the average price of purchases was more than 10% over ... https://seekingalpha.com/news/1110202?source=tweet\" data-url=\"https://seekingalpha.com/news/1110202\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110172\" data-ts=\"1372347342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMC\" target=\"_blank\">CMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110172\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Commercial Metals (CMC +3.6%) climbs higher even after FQ3 missed expectations. CMC says a...</a></h4><p>Commercial Metals (<a href=\"https://seekingalpha.com/symbol/CMC\" title=\"Commercial Metals Company\">CMC</a> <font color=\"green\">+3.6%</font>) climbs higher even after FQ3 <a href=\"https://seekingalpha.com/currents/post/1109022\" target=\"_blank\">missed expectations</a>. CMC says a modest improvement in rebar shipments was more than offset by weaker shipment levels of merchant and light structural products, resulting in lower profitability at its Americas Mills business. Operationally, CMC anticipates FQ4 results similar to FQ3; consensus estimates are $0.25 EPS and $1.93B in revenues.</p><div class=\"tiny-share-widget\" data-id=\"1110172\" data-linked=\"Commercial Metals (CMC +3.6%) climbs higher even after FQ3 missed expectations. CMC says a...\" data-tweet=\"$CMC - Commercial Metals (CMC +3.6%) climbs higher even after FQ3 missed expectations. CMC says a modest improvement in rebar shipments was more than offset by weaker shipment levels of merchant and light structural products, resulting in lower profitab... https://seekingalpha.com/news/1110172?source=tweet\" data-url=\"https://seekingalpha.com/news/1110172\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110162\" data-ts=\"1372347228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZGNX\" target=\"_blank\">ZGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110162\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zogenix (ZGNX +1.8%) announces a co-promotion agreement with Valeant (VRX +1%) for the latter&#39;s...</a></h4><p>Zogenix (<a href=\"https://seekingalpha.com/symbol/ZGNX\" title=\"Zogenix, Inc.\">ZGNX</a> <font color=\"green\">+1.8%</font>) announces a co-promotion agreement with Valeant (VRX <font color=\"green\">+1%</font>) for the latter's Migranal nasal spray. ZGNX will utilize its sales force to market the product to prescribers and will \"be compensated in the form of a quarterly service fee that is calculated as a percentage of net sales over a baseline amount.\" (PR)</p><div class=\"tiny-share-widget\" data-id=\"1110162\" data-linked=\"Zogenix (ZGNX +1.8%) announces a co-promotion agreement with Valeant (VRX +1%) for the latter&#39;s...\" data-tweet=\"$ZGNX $ZGNX $BHC - Zogenix (ZGNX +1.8%) announces a co-promotion agreement with Valeant (VRX +1%) for the latter&#39;s Migranal nasal spray. ZGNX will utilize its sales force to market the product to prescribers and will &quot;be compensated in the form of a qua... https://seekingalpha.com/news/1110162?source=tweet\" data-url=\"https://seekingalpha.com/news/1110162\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110152\" data-ts=\"1372347100\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLS\" target=\"_blank\">XLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110152\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exelis (XLS +2.2%) has received a $3.2M contract from Ball&#39;s (NYSE:BLL) Aerospace &amp;amp;...</a></h4><p>Exelis (<a href=\"https://seekingalpha.com/symbol/XLS\" title=\"Exelis Inc.\">XLS</a> <font color=\"green\">+2.2%</font>) has received a $3.2M contract from Ball's (NYSE:<a href=\"https://seekingalpha.com/symbol/BLL\" title=\"Ball Corporation\">BLL</a>) Aerospace &amp; Technologies subsidiary to design an advanced receiver chain for the U.S. Air Force Weather Satellite Follow-on program. The new design will improve measurements of ocean surface winds, which is used for severe weather forecasting.</p><div class=\"tiny-share-widget\" data-id=\"1110152\" data-linked=\"Exelis (XLS +2.2%) has received a $3.2M contract from Ball&#39;s (NYSE:BLL) Aerospace &amp;amp;...\" data-tweet=\"$XLS $XLS $BLL - Exelis (XLS +2.2%) has received a $3.2M contract from Ball&#39;s (NYSE:BLL) Aerospace &amp; Technologies subsidiary to design an advanced receiver chain for the U.S. Air Force Weather Satellite Follow-on program. The new design will improve mea... https://seekingalpha.com/news/1110152?source=tweet\" data-url=\"https://seekingalpha.com/news/1110152\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110142\" data-ts=\"1372345989\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EPZM\" target=\"_blank\">EPZM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110142\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Epizyme&amp;nbsp;(EPZM +2.4%) trades higher after Wedbush&#39;s Greg Wade ramps up coverage with an...</a></h4><p>Epizyme (<a href=\"https://seekingalpha.com/symbol/EPZM\" title=\"Epizyme\">EPZM</a> <font color=\"green\">+2.4%</font>) trades higher after Wedbush's Greg Wade <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/06/3711667/update-wedbush-initiates-epizyme-at-outperform-on-therap\" target=\"_blank\">ramps up coverage</a> with an Outperform rating and a $37 price target. Wade says that advances in genetically defining sub-sets of cancer patients have led to identifying certain histone methyltransferase proteins as key malignant drivers, and <a href=\"https://seekingalpha.com/symbol/EPZM\" title=\"Epizyme\">EPZM</a>'s small molecule drug discovery platform is key to marrying these antagonists with the genetically definable malignancy.</p><div class=\"tiny-share-widget\" data-id=\"1110142\" data-linked=\"Epizyme (EPZM +2.4%) trades higher after Wedbush&#39;s Greg Wade ramps up coverage with an...\" data-tweet=\"$EPZM - Epizyme (EPZM +2.4%) trades higher after Wedbush&#39;s Greg Wade ramps up coverage with an Outperform rating and a $37 price target. Wade says that advances in genetically defining sub-sets of cancer patients have led to identifying certain histone ... https://seekingalpha.com/news/1110142?source=tweet\" data-url=\"https://seekingalpha.com/news/1110142\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110132\" data-ts=\"1372345766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REGN\" target=\"_blank\">REGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110132\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman&#39;s Terence Flynn says a study published in a medical journal suggests branded VEGF drugs...</a></h4><p>Goldman's Terence Flynn says a study published in a medical journal suggests branded VEGF drugs such as Regeneron's (<a href=\"https://seekingalpha.com/symbol/REGN\" title=\"Regeneron Pharmaceuticals, Inc.\">REGN</a> <font color=\"green\">+2.7%</font>) Eylea \"<a href=\"http://www.streetinsider.com/Analyst+Comments/Regeneron+%28REGN%29+Sees+Upside+Following+Study+on+LucentisAvastin+in+DME/8455451.html\" target=\"_blank\">are superior</a> to off-label Avastin.\" In the cited study, patients on Lucentis realized a 13 letter improvement in vision versus an 11 letter improvement for those on Avastin.</p><div class=\"tiny-share-widget\" data-id=\"1110132\" data-linked=\"Goldman&#39;s Terence Flynn says a study published in a medical journal suggests branded VEGF drugs...\" data-tweet=\"$REGN - Goldman&#39;s Terence Flynn says a study published in a medical journal suggests branded VEGF drugs such as Regeneron&#39;s (REGN +2.7%) Eylea &quot;are superior to off-label Avastin.&quot; In the cited study, patients on Lucentis realized a 13 letter improvement... https://seekingalpha.com/news/1110132?source=tweet\" data-url=\"https://seekingalpha.com/news/1110132\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110052\" data-ts=\"1372344401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLDM\" target=\"_blank\">FLDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110052\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fluidigm (FLDM +2.5%) moves up this morning after Maxim Group initiates coverage with a Buy...</a></h4><p>Fluidigm (<a href=\"https://seekingalpha.com/symbol/FLDM\" title=\"Fluidigm Corporation\">FLDM</a> <font color=\"green\">+2.5%</font>) moves up this morning after Maxim Group <a href=\"http://www.streetinsider.com/New+Coverage/Maxim+Group+Starts+Fluidigm+Corporation+%28FLDM%29+at+Buy/8454482.html\" target=\"_blank\">initiates coverage</a> with a Buy rating and a $21 price target.</p><div class=\"tiny-share-widget\" data-id=\"1110052\" data-linked=\"Fluidigm (FLDM +2.5%) moves up this morning after Maxim Group initiates coverage with a Buy...\" data-tweet=\"$FLDM - Fluidigm (FLDM +2.5%) moves up this morning after Maxim Group initiates coverage with a Buy rating and a $21 price target. https://seekingalpha.com/news/1110052?source=tweet\" data-url=\"https://seekingalpha.com/news/1110052\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1110032\" data-ts=\"1372344161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INVN\" target=\"_blank\">INVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1110032\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InvenSense (INVN +3.1%) has indeed scored its first iPhone motion sensor design win, says OTR...</a></h4><p>InvenSense (<a href=\"https://seekingalpha.com/symbol/INVN\" title=\"InvenSense\">INVN</a> <font color=\"green\">+3.1%</font>) has indeed scored its first iPhone motion sensor design win, <a href=\"https://twitter.com/thenotablecalls/status/350245744176939010\" target=\"_blank\">says OTR Global</a> in a note boosting shares. Goldman, <a href=\"https://seekingalpha.com/currents/post/1085212\" target=\"_blank\">one of several firms</a> to have already reported of or predicted an iPhone 5S win, thinks the win could lift EPS by ~60%.</p><div class=\"tiny-share-widget\" data-id=\"1110032\" data-linked=\"InvenSense (INVN +3.1%) has indeed scored its first iPhone motion sensor design win, says OTR...\" data-tweet=\"$INVN - InvenSense (INVN +3.1%) has indeed scored its first iPhone motion sensor design win, says OTR Global in a note boosting shares. Goldman, one of several firms to have already reported of or predicted an iPhone 5S win, thinks the win could lift EP... https://seekingalpha.com/news/1110032?source=tweet\" data-url=\"https://seekingalpha.com/news/1110032\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1109972\" data-ts=\"1372343305\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDW\" target=\"_blank\">CDW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1109972\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sometimes setting the bar low is a good thing: After gradually lowering the price of its IPO to...</a></h4><p>Sometimes setting the bar low is a good thing: After <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1108722\">gradually lowering</a> the price of its IPO to $17 from a range of $20-$23, <a href=\"https://seekingalpha.com/symbol/CDW\" title=\"CDW Corporation\">CDW</a> opened for trading at $17.64 and is currently at $17.97, <font color=\"green\">up 5.7%</font>. That gives the giant IT hardware distributor a valuation of $3.03B, or 0.3x 2012 sales and 16x earnings. (<a target=\"_blank\" href=\"http://www.sec.gov/Archives/edgar/data/1402057/000119312513271895/d501911ds1a.htm\">S-1</a>) (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/908151\">Q1 figures</a>)</p><div class=\"tiny-share-widget\" data-id=\"1109972\" data-linked=\"Sometimes setting the bar low is a good thing: After gradually lowering the price of its IPO to...\" data-tweet=\"$CDW - Sometimes setting the bar low is a good thing: After gradually lowering the price of its IPO to $17 from a range of $20-$23, CDW opened for trading at $17.64 and is currently at $17.97, up 5.7%. That gives the giant IT hardware distributor a valu... https://seekingalpha.com/news/1109972?source=tweet\" data-url=\"https://seekingalpha.com/news/1109972\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1109942\" data-ts=\"1372342573\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRA\" target=\"_blank\">TLRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1109942\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tremor Video&#39;s (TRMR) IPO isn&#39;t faring well. After pricing its 7.5M-share offering at $10, below...</a></h4><p>Tremor Video's (TRMR) IPO isn't faring well. After pricing its 7.5M-share offering at $10, below a range of $11-$13, shares opened at $11 but have quickly fallen to $9.65, which translates into a <font color=\"red\">3.5% drop</font>. That gives the provider of online/mobile video ad tech solutions a market cap of $468M, or 4.4x 2012 sales. Tremor posted Q1 revenue of $24.8M (+43% Y/Y), and a net loss of $9.1M. Tremor's <a href=\"http://www.tremorvideo.com/our-technology/\" target=\"_blank\">VideoHub tech</a> analyzes online videos and their context, as well as an ad campaign's goals and performance, to deliver targeted ads. The company considers YouTube, Hulu, and video ad networks such as <a href=\"http://www.bloomberg.com/news/2013-01-30/google-fends-off-brightroll-in-7-6-billion-video-market.html\" target=\"_blank\">BrightRoll</a> to be among its competitors. (<a href=\"http://www.sec.gov/Archives/edgar/data/1375796/000104746913006961/a2215601zs-1a.htm\" target=\"_blank\">S-1</a>) (<a href=\"https://seekingalpha.com/article/1523562-ipo-preview-2-new-video-digital-ipos-for-week-of-june-24th?source=cc\" target=\"_blank\">IPO preview</a>)</p><div class=\"tiny-share-widget\" data-id=\"1109942\" data-linked=\"Tremor Video&#39;s (TRMR) IPO isn&#39;t faring well. After pricing its 7.5M-share offering at $10, below...\" data-tweet=\"$TLRA - Tremor Video&#39;s (TRMR) IPO isn&#39;t faring well. After pricing its 7.5M-share offering at $10, below a range of $11-$13, shares opened at $11 but have quickly fallen to $9.65, which translates into a 3.5% drop. That gives the provider of online/mobi... https://seekingalpha.com/news/1109942?source=tweet\" data-url=\"https://seekingalpha.com/news/1109942\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1109872\" data-ts=\"1372341553\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIDU\" target=\"_blank\">BIDU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1109872\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A roundup of tech ratings changes: 1) BNP Paribas has started Baidu (BIDU +1.6%) at Buy. 2)...</a></h4>A roundup of tech ratings changes: 1) BNP Paribas has started Baidu (<a href='https://seekingalpha.com/symbol/BIDU' title='Baidu, Inc.'>BIDU</a> <font color=\"green\">+1.6%</font>) at Buy. 2) Longbow has upgraded Seagate (<a href='https://seekingalpha.com/symbol/STX' title='Seagate Technology'>STX</a> <font color=\"green\">+4.1%</font>) and Western Digital (<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a> <font color=\"green\">+2.9%</font>) to Buy. 3) Pac Crest has started Synchronoss (<a href='https://seekingalpha.com/symbol/SNCR' title='Synchronoss Technologies, Inc.'>SNCR</a> <font color='green'>+2.9%</font>) at Outperform. 4) Lazard has upgraded Trimble (<a href='https://seekingalpha.com/symbol/TRMB' title='Trimble, Inc.'>TRMB</a> <font color=\"green\">+2.5%</font>) to Buy. 5) BMO and RBC have downgraded Rogers (<a href='https://seekingalpha.com/symbol/RCI' title='Rogers Communications Inc.'>RCI</a> <font color=\"red\">-1.9%</font>) to Market Perform/Sector Perform, and BMO has also downgraded Telus (<a href='https://seekingalpha.com/symbol/TU' title='TELUS Corporation'>TU</a> <font color=\"red\">-2.4%</font>) to Market Perform. However, Stifel has upgraded Telus to Buy. (<a href=\"https://seekingalpha.com/currents/post/1107412\" target=\"_blank\">yesterday</a>). 6) HSBC has upgraded Sohu (<a href='https://seekingalpha.com/symbol/SOHU' title='Sohu.com Inc.'>SOHU</a> <font color=\"green\">+3.8%</font>) to Neutral. 7) China Mobile (<a href='https://seekingalpha.com/symbol/CHL' title='China Mobile Limited'>CHL</a> <font color=\"green\">+1.7%</font>) has been upgraded to Neutral by BofA/Merrill. 8) Atmel (<a href='https://seekingalpha.com/symbol/ATML' title='Atmel Corporation'>ATML</a> <font color=\"green\">+1.4%</font>) has been upgraded to Buy by Lazard. 9) Flir Systems (<a href='https://seekingalpha.com/symbol/FLIR' title='FLIR Systems, Inc.'>FLIR</a> <font color=\"green\">+2.1%</font>) has been upgraded to Overweight by Stephens.<div class=\"tiny-share-widget\" data-id=\"1109872\" data-linked=\"A roundup of tech ratings changes: 1) BNP Paribas has started Baidu (BIDU +1.6%) at Buy. 2)...\" data-tweet=\"$BIDU $BIDU $STX - A roundup of tech ratings changes: 1) BNP Paribas has started Baidu (BIDU +1.6%) at Buy. 2) Longbow has upgraded Seagate (STX +4.1%) and Western Digital (WDC +2.9%) to Buy. 3) Pac Crest has started Synchronoss (SNCR +2.9%) at Outperfo... https://seekingalpha.com/news/1109872?source=tweet\" data-url=\"https://seekingalpha.com/news/1109872\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1109802\" data-ts=\"1372340882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBH\" target=\"_blank\">KBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1109802\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on KB Home (KBH +3.7%) FQ2: Net loss narrows to $2.97M from $24.14M a year earlier. Homes...</a></h4><p>More on KB Home (<a href=\"https://seekingalpha.com/symbol/KBH\" title=\"KB Home\">KBH</a> <font color=\"green\">+3.7%</font>) <a href=\"https://seekingalpha.com/currents/post/1109432\" target=\"_blank\">FQ2</a>: Net loss <a href=\"http://www.bloomberg.com/news/2013-06-27/kb-home-reports-narrower-loss-after-73-jump-in-revenue.html\" target=\"_blank\">narrows</a> to $2.97M from $24.14M a year earlier. Homes delivered +39% Q/Q to 1,797; Net orders +6% Y/Y to 2,162 units; backlog +6% to 3,128 homes; average selling price +25% to $290,400, the highest for a Q2 since 2006. CEO Jeffrey Mezger is confident that KB Home will achieve \"a solidly profitable 2013,\" with \"meaningful profits\" in H2, and that it \"will continue to build positive momentum entering 2014.\"</p><div class=\"tiny-share-widget\" data-id=\"1109802\" data-linked=\"More on KB Home (KBH +3.7%) FQ2: Net loss narrows to $2.97M from $24.14M a year earlier. Homes...\" data-tweet=\"$KBH - More on KB Home (KBH +3.7%) FQ2: Net loss narrows to $2.97M from $24.14M a year earlier. Homes delivered +39% Q/Q to 1,797; Net orders +6% Y/Y to 2,162 units; backlog +6% to 3,128 homes; average selling price +25% to $290,400, the highest for a Q... https://seekingalpha.com/news/1109802?source=tweet\" data-url=\"https://seekingalpha.com/news/1109802\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1109752\" data-ts=\"1372339827\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTATQ\" target=\"_blank\">GTATQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1109752\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GT&amp;nbsp;Advanced Tech (GTAT) +8.8% premarket after Canaccord upgrades shares to Buy from Hold...</a></h4><p>GT Advanced Tech (GTAT) <font color=\"green\">+8.8%</font> premarket after Canaccord <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/06/3711631/update-canaccord-genuity-upgrades-gt-advanced-technologi\" target=\"_blank\">upgrades shares to Buy</a> from Hold with a $5 price target (up from $4), saying both the economics and investor sentiment in GTAT's solar and sapphire businesses are improving. While it does not expect an explosion in solar demand, the firm foresees a tightening in polysilicon as soon as 2015 with modest solar installation growth.</p><div class=\"tiny-share-widget\" data-id=\"1109752\" data-linked=\"GT Advanced Tech (GTAT) +8.8% premarket after Canaccord upgrades shares to Buy from Hold with a...\" data-tweet=\"$GTATQ - GT Advanced Tech (GTAT) +8.8% premarket after Canaccord upgrades shares to Buy from Hold with a $5 price target (up from $4), saying both the economics and investor sentiment in GTAT&#39;s solar and sapphire businesses are improving. While it does ... https://seekingalpha.com/news/1109752?source=tweet\" data-url=\"https://seekingalpha.com/news/1109752\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1109722\" data-ts=\"1372339449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCEL\" target=\"_blank\">FCEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1109722\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FuelCell Energy (NASDAQ:FCEL) +3.2% premarket after saying it netted ~$36M from finalizing its...</a></h4><p>FuelCell Energy (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FCEL\" title=\"FuelCell Energy, Inc.\">FCEL</a>) <font color=\"green\">+3.2%</font> premarket after saying it netted ~$36M from finalizing its $38M debt issue to fund ongoing refinement and marketing of its alternative-power supply technologies. Shares also may be getting an assist from Toyota's (NYSE:<a href=\"https://seekingalpha.com/symbol/TM\" title=\"Toyota Motor Corporation\">TM</a>) plans to <a href=\"http://www.bloomberg.com/news/2013-06-26/toyota-seeks-prius-like-success-with-2015-fuel-cell-model.html\" target=\"_blank\">introduce a new hydrogen-powered sedan</a> at the Tokyo Auto Show in November.</p><div class=\"tiny-share-widget\" data-id=\"1109722\" data-linked=\"FuelCell Energy (NASDAQ:FCEL) +3.2% premarket after saying it netted ~$36M from finalizing its...\" data-tweet=\"$FCEL $FCEL $TM - FuelCell Energy (NASDAQ:FCEL) +3.2% premarket after saying it netted ~$36M from finalizing its $38M debt issue to fund ongoing refinement and marketing of its alternative-power supply technologies. Shares also may be getting an assist ... https://seekingalpha.com/news/1109722?source=tweet\" data-url=\"https://seekingalpha.com/news/1109722\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1109692\" data-ts=\"1372339244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1109692\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Market preview: European shares and U.S. stock futures are higher, with not even positive data...</a></h4><b>Market preview:</b> European shares and <a href=\"http://online.wsj.com/article/SB10001424127887323419604578571052685583658.html\" target=\"_blank\">U.S. stock futures</a> are higher, with not even positive data for <a href=\"https://seekingalpha.com/currents/post/1109422\" target=\"_blank\">consumer spending</a> and <a href=\"https://seekingalpha.com/currents/post/1109392\" target=\"_blank\">weekly jobless</a> claims being able to spoil the mood. A bunch of Fed officials are due to speak today, when they'll probably trot out the party line that QE is here to stay for the time being. The S&amp;P Mini is <font color=\"green\">+0.6%</font>. <a href=\"https://seekingalpha.com/currents/post/1108262\" target=\"_blank\">Later</a>: Bloomberg Consumer Comfort Index, Pending Home Sales, Kansas City Fed Mfg Survey<div class=\"tiny-share-widget\" data-id=\"1109692\" data-linked=\"Market preview: European shares and U.S. stock futures are higher, with not even positive data...\" data-tweet=\"Market preview: European shares and U.S. stock futures are higher, with not even positive data for consumer spending and weekly jobless claims being able to spoil the mood. A bunch of Fed officials are due to speak today, when they&#39;ll probably trot out ... https://seekingalpha.com/news/1109692?source=tweet\" data-url=\"https://seekingalpha.com/news/1109692\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1109672\" data-ts=\"1372338969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YELP\" target=\"_blank\">YELP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1109672\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yelp (NYSE:YELP) +2.8%, adding to yesterday&#39;s 12% gain, after Cowen says a survey points to...</a></h4>Yelp (NYSE:<a href='https://seekingalpha.com/symbol/YELP' title='Yelp'>YELP</a>) <font color=\"green\">+2.8%</font>, adding to <a href=\"https://seekingalpha.com/currents/post/1108512\" target=\"_blank\">yesterday's</a> 12% gain, after <a href=\"http://finance.yahoo.com/news/yelp-tremendous-runway-growth-says-123304522.html\" target=\"_blank\">Cowen</a> says a survey points to growing local business awareness/engagement. The firm adds a majority of respondents were still unaware of Yelp, leaving plenty of room for growth.<div class=\"tiny-share-widget\" data-id=\"1109672\" data-linked=\"Yelp (NYSE:YELP) +2.8%, adding to yesterday&#39;s 12% gain, after Cowen says a survey points to...\" data-tweet=\"$YELP - Yelp (NYSE:YELP) +2.8%, adding to yesterday&#39;s 12% gain, after Cowen says a survey points to growing local business awareness/engagement. The firm adds a majority of respondents were still unaware of Yelp, leaving plenty of room for growth. https://seekingalpha.com/news/1109672?source=tweet\" data-url=\"https://seekingalpha.com/news/1109672\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1109662\" data-ts=\"1372338819\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CERE\" target=\"_blank\">CERE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1109662\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: CERE +15%. GTAT +9%. UMC +7%. RSOL +5%.Losers: NBG -28%. PPHM -28%. SIR...</a></h4><b>Premarket gainers:</b> <a href=\"https://seekingalpha.com/symbol/CERE\" title=\"Ceres, Inc.\">CERE</a> <font color=\"green\">+15%</font>. GTAT <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/UMC\" title=\"United Microelectronics Corporation\">UMC</a> <font color=\"green\">+7%</font>. RSOL <font color=\"green\">+5%</font>.<br><b>Losers:</b> NBG <font color=\"red\">-28%</font>. PPHM <font color=\"red\">-28%</font>. <a href=\"https://seekingalpha.com/symbol/SIR\" title=\"Select Income REIT\">SIR</a> <font color=\"red\">-6%</font>. <div class=\"tiny-share-widget\" data-id=\"1109662\" data-linked=\"Premarket gainers: CERE +15%. GTAT +9%. UMC +7%. RSOL +5%.Losers: NBG -28%. PPHM -28%. SIR -6%. \" data-tweet=\"$CERE $CERE $GTATQ - Premarket gainers: CERE +15%. GTAT +9%. UMC +7%. RSOL +5%.Losers: NBG -28%. PPHM -28%. SIR -6%.  https://seekingalpha.com/news/1109662?source=tweet\" data-url=\"https://seekingalpha.com/news/1109662\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1109632\" data-ts=\"1372338526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1109632\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Southeast Asian shares extend Wednesday&#39;s rally amid cautious foreign buying with Philippine...</a></h4>Southeast Asian shares extend <a href=\"https://seekingalpha.com/currents/post/1106452\" target=\"_blank\">Wednesday's rally</a> amid <a href=\"http://uk.reuters.com/article/2013/06/27/markets-southeastasia-stocks-idUKL3N0F32BH20130627\" target=\"_blank\">cautious foreign buying</a> with Philippine equities (<a href='https://seekingalpha.com/symbol/ephe' title='iShares MSCI Philippines Investable Market Index ETF'>EPHE</a>) leading the charge, up <font color=\"green\">3.4%</font> in Manila. Elsewhere, Indonesian (<a href='https://seekingalpha.com/symbol/eido' title='iShares MSCI Indonesia Investable Market Index ETF'>EIDO</a>, <a href='https://seekingalpha.com/symbol/idx' title='Market Vectors Indonesia Index ETF'>IDX</a>), Thai (<a href='https://seekingalpha.com/symbol/thd' title='iShares MSCI Thailand Capped Investable Market Index ETF'>THD</a>), and Malaysian (<a href='https://seekingalpha.com/symbol/ewm' title='iShares MSCI Malaysia Index ETF'>EWM</a>) stocks rise <font color=\"green\">1.9%</font>, <font color=\"green\">1.55%</font>, and <font color=\"green\">0.62%</font> respectively, while the Straits Times (<a href='https://seekingalpha.com/symbol/ews' title='iShares MSCI Singapore Index ETF'>EWS</a>, <a href='https://seekingalpha.com/symbol/ewss' title='iShares MSCI Singapore Small Cap Index ETF'>EWSS</a>) creeps up <font color=\"green\">0.4%</font>.<div class=\"tiny-share-widget\" data-id=\"1109632\" data-linked=\"Southeast Asian shares extend Wednesday&#39;s rally amid cautious foreign buying with Philippine...\" data-tweet=\"$EPHE $EIDO $IDX - Southeast Asian shares extend Wednesday&#39;s rally amid cautious foreign buying with Philippine equities (EPHE) leading the charge, up 3.4% in Manila. Elsewhere, Indonesian (EIDO, IDX), Thai (THD), and Malaysian (EWM) stocks rise 1.9%, 1... https://seekingalpha.com/news/1109632?source=tweet\" data-url=\"https://seekingalpha.com/news/1109632\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1109372\" data-ts=\"1372336125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1109372\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of DirecTV (NYSE:DTV) are down 3.6% premarket after the company disclosed that its unit...</a></h4><p>Shares of DirecTV (NYSE:<a href=\"https://seekingalpha.com/symbol/DTV\" title=\"DTE Energy Company Corporate Units Cons 1/20 of 1000 USD of Nom Nts + 1 PC\">DTV</a>) are <font color=\"red\">down 3.6%</font> premarket after the company disclosed that its unit in Latin America <a href=\"https://seekingalpha.com/currents/post/1108952\" target=\"_blank\">reported</a> subscribers numbers which were boosted higher by artificial means. Shares of DTV hit an all-time high after growth in Latin America helped the company beat Q1 profit estimates.</p><div class=\"tiny-share-widget\" data-id=\"1109372\" data-linked=\"Shares of DirecTV (NYSE:DTV) are down 3.6% premarket after the company disclosed that its unit...\" data-tweet=\"$T - Shares of DirecTV (NYSE:DTV) are down 3.6% premarket after the company disclosed that its unit in Latin America reported subscribers numbers which were boosted higher by artificial means. Shares of DTV hit an all-time high after growth in Latin Ame... https://seekingalpha.com/news/1109372?source=tweet\" data-url=\"https://seekingalpha.com/news/1109372\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1109352\" data-ts=\"1372336013\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRX\" target=\"_blank\">CPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1109352\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharmaceutical (CPRX +3.3%) reiterates that it expects to complete the enrollment of 36...</a></h4><p>Catalyst Pharmaceutical (<a href=\"https://seekingalpha.com/symbol/CPRX\" title=\"Catalyst Pharmaceuticals, Inc.\">CPRX</a> <font color=\"green\">+3.3%</font>) reiterates that it expects to complete the enrollment of 36 patients in the Phase III trial of the Firdapse drug for Lambert-Eaton Myasthenic Syndrome, a rare and sometimes fatal autoimmune disease characterized by muscle weakness, during Q4 2013. Assuming all goes well, Catalyst expects to file an NDA for Firdapse in Q1 2015, obtain FDA authorization at the end of that year, and launch the treatment in H1 2016. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1109352\" data-linked=\"Catalyst Pharmaceutical (CPRX +3.3%) reiterates that it expects to complete the enrollment of 36...\" data-tweet=\"$CPRX - Catalyst Pharmaceutical (CPRX +3.3%) reiterates that it expects to complete the enrollment of 36 patients in the Phase III trial of the Firdapse drug for Lambert-Eaton Myasthenic Syndrome, a rare and sometimes fatal autoimmune disease characteri... https://seekingalpha.com/news/1109352?source=tweet\" data-url=\"https://seekingalpha.com/news/1109352\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1109172\" data-ts=\"1372333917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBGGY\" target=\"_blank\">NBGGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1109172\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">National Bank of Greece (NBG) plummets 26% premarket as a report regulators may lift a ban on...</a></h4><p>National Bank of Greece (NBG) <font color=\"red\">plummets 26%</font> premarket as a report regulators may <a href=\"http://247wallst.com/2013/06/27/one-more-implosion-for-national-bank-of-greece/\" target=\"_blank\">lift a ban</a> on short-selling of the nation's banks adds to the lender's well-publicized woes. The stock's off more than 40% since May's recapitalization and reverse split.</p><div class=\"tiny-share-widget\" data-id=\"1109172\" data-linked=\"National Bank of Greece (NBG) plummets 26% premarket as a report regulators may lift a ban on...\" data-tweet=\"$NBGGY - National Bank of Greece (NBG) plummets 26% premarket as a report regulators may lift a ban on short-selling of the nation&#39;s banks adds to the lender&#39;s well-publicized woes. The stock&#39;s off more than 40% since May&#39;s recapitalization and reverse ... https://seekingalpha.com/news/1109172?source=tweet\" data-url=\"https://seekingalpha.com/news/1109172\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1108842\" data-ts=\"1372321364\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FEZ\" target=\"_blank\">FEZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1108842\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European shares (NYSEARCA:FEZ) are mixed after being boosted yesterday by the hope that Fed...</a></h4>European shares (NYSEARCA:<a href='https://seekingalpha.com/symbol/FEZ' title='SPDR EURO STOXX 50 ETF'>FEZ</a>) are mixed after being boosted yesterday by the hope that Fed bond-buying has some ways to go following poor U.S. GDP numbers, and ahead of a <a href=\"https://seekingalpha.com/currents/post/1108262\" target=\"_blank\">heavy day</a> of data today. EU Stoxx 50 <font color=\"red\">-0.1%</font>, London <font color=\"green\">+0.4%</font>, Paris <font color=\"red\">-0.1%</font>, Frankfurt flat, Madrid <font color=\"red\">-0.4%</font>, Milan <font color=\"green\">+0.1%</font>.<div class=\"tiny-share-widget\" data-id=\"1108842\" data-linked=\"European shares (NYSEARCA:FEZ) are mixed after being boosted yesterday by the hope that Fed...\" data-tweet=\"$FEZ - European shares (NYSEARCA:FEZ) are mixed after being boosted yesterday by the hope that Fed bond-buying has some ways to go following poor U.S. GDP numbers, and ahead of a heavy day of data today. EU Stoxx 50 -0.1%, London +0.4%, Paris -0.1%, Fra... https://seekingalpha.com/news/1108842?source=tweet\" data-url=\"https://seekingalpha.com/news/1108842\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1108832\" data-ts=\"1372321298\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1108832\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\"> Asian shares mostly rise as markets breath a sigh of relief over yesterday&#39;s sharp downward...</a></h4><a href=\"http://www.marketwatch.com/story/korean-stocks-lead-asia-gains-amid-fed-hopes-2013-06-26\" target=\"_blank\"> Asian shares mostly rise</a> as markets breath a sigh of relief over yesterday's sharp downward revision of Q1 U.S. GDP, which, so it's hoped, could prompt the Fed to delay the tapering of its QE program. Japanese stocks (<a href=\"https://seekingalpha.com/symbol/dxj\" title=\"WisdomTree Japan Hedged Equity ETF\">DXJ</a>) <font color=\"green\">climb 3%</font> as the USD-JPY <font color=\"green\">rises 0.4%</font> to ¥98.13, although China continues to struggle over concerns about PBOC tightening. Hong Kong <font color=\"green\">+0.5%</font>, China <font color=\"red\">-0.1%</font>, India <font color=\"green\">+1.5%</font> and Australia (<a href=\"https://seekingalpha.com/symbol/ewa\" title=\"iShares MSCI Australia ETF\">EWA</a>) <font color=\"green\">+1.7%</font> following the <a href=\"https://seekingalpha.com/currents/post/1105952\" target=\"_blank\">palace coup</a> that ousted PM Julia Gillard.<div class=\"tiny-share-widget\" data-id=\"1108832\" data-linked=\" Asian shares mostly rise as markets breath a sigh of relief over yesterday&#39;s sharp downward...\" data-tweet=\"$DXJ $EWA $EWJ - Asian shares mostly rise as markets breath a sigh of relief over yesterday&#39;s sharp downward revision of Q1 U.S. GDP, which, so it&#39;s hoped, could prompt the Fed to delay the tapering of its QE program. Japanese stocks (DXJ) climb 3% as t... https://seekingalpha.com/news/1108832?source=tweet\" data-url=\"https://seekingalpha.com/news/1108832\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 AM </div></div></li>","count":59,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}